These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2306482)

  • 1. Studies on the lecithin: cholesterol acyltransferase substrate properties of HDL as determined by its subclass distribution analysed by gradient gel electrophoresis.
    Karpe F; Johansson J; Carlson LA
    Biochim Biophys Acta; 1990 Feb; 1042(3):310-4. PubMed ID: 2306482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.
    Albers JJ; Chen CH; Adolphson JL
    J Lipid Res; 1981 Nov; 22(8):1206-13. PubMed ID: 7320631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age related changes in the lipoprotein substrates for the esterification of plasma cholesterol in rats.
    Lee SM; Kudchodkar BJ; Lacko AG
    Mech Ageing Dev; 1991 Nov; 61(1):85-98. PubMed ID: 1779703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fatty acid modification of HDL phospholipid molecular species alters lecithin: cholesterol acyltransferase reactivity in cynomolgus monkeys.
    Thornburg JT; Parks JS; Rudel LL
    J Lipid Res; 1995 Feb; 36(2):277-89. PubMed ID: 7751815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase to HDL size distribution.
    Huesca-Gómez C; Carreón-Torres E; Nepomuceno-Mejía T; Sánchez-Solorio M; Galicia-Hidalgo M; Mejía AM; Montaño LF; Franco M; Posadas-Romero C; Pérez-Méndez O
    Endocr Res; 2004 Aug; 30(3):403-15. PubMed ID: 15554357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
    Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
    Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase.
    Gong EL; Nichols AV; Weisgraber KH; Forte TM; Shore VG; Blanche PJ
    Biochim Biophys Acta; 1989 Dec; 1006(3):317-28. PubMed ID: 2597674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction.
    Subbaiah PV; Liu M
    J Biol Chem; 1993 Sep; 268(27):20156-63. PubMed ID: 8376375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HDL2b lipoproteins as an acceptor of cholesterol from erythrocyte membrane and the role of lecithin-cholesterol-acyltransferase during this process].
    Nikiforova AA; Kheĭfets GM; Alksnis EG; Parfenova NS; Klimov AN
    Biokhimiia; 1988 Aug; 53(8):1334-8. PubMed ID: 3191196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of human high density lipoprotein: presence of lipoproteins with and without apoE and their roles as substrates for lecithin:cholesterol acyltransferase reaction.
    Marcel YL; Vezina C; Emond D; Suzue G
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2969-73. PubMed ID: 6930680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein.
    Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM
    Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lecithin: cholesterol acyltransferase. An exercise in comparative biology.
    Glomset JA
    Prog Biochem Pharmacol; 1979; 15():41-66. PubMed ID: 224398
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoprotein substrates for plasma cholesterol esterification. Influence of particle size and composition of the high density lipoprotein subfraction 3.
    Barter PJ; Hopkins GJ; Gorjatschko L
    Atherosclerosis; 1985 Dec; 58(1-3):97-107. PubMed ID: 4091887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of total parenteral nutrition with intravenous fat on lipids and high density lipoprotein heterogeneity in neonates.
    Forte TM; Genzel-Boroviczeny O; Austin MA; Kao LC; Scott C; Albers JJ; D'Harlingue AE
    JPEN J Parenter Enteral Nutr; 1989; 13(5):490-500. PubMed ID: 2514290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the interaction of lecithin: cholesterol acyltransferase with subfractions of high density lipoproteins.
    Jahani M; Lacko AG
    J Lipid Res; 1981 Sep; 22(7):1102-10. PubMed ID: 7299290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on human serum high-density lipoproteins. VI. Studies on a cholesterol ester-releasing reaction in vitro.
    Olofsson SO; Fager G; Gustafson A
    Scand J Clin Lab Invest; 1976 Sep; 36(5):481-8. PubMed ID: 185685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lecithin:cholesterol acyltransferase activity in relation to lipoprotein concentration and lipid composition.
    Leiss O; Murawski U; Egge H
    Scand J Clin Lab Invest Suppl; 1978; 150():77-84. PubMed ID: 218279
    [No Abstract]   [Full Text] [Related]  

  • 18. High density lipoprotein alterations induced by bezafibrate in healthy male volunteers.
    Moulin P; Bourdillon MC; de Parscau L; Perrot L; Ponsin G; Berthezene F
    Atherosclerosis; 1987 Sep; 67(1):17-22. PubMed ID: 3675703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different methods of isotopically labelling the esterified cholesterol in human high density lipoproteins.
    Barter PJ; Gorjatschko L; Hopkins GJ
    Biochim Biophys Acta; 1982 Mar; 710(3):349-58. PubMed ID: 7041983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.